N. Prior

发表

Expression of α‐defensin 1–3 in T cells from severe cutaneous drug‐induced hypersensitivity reactions

T. Bellón, M. Blanca, A. Fiandor, 2011, Allergy.

Management of angioedema without urticaria in the emergency department

I. Jáuregui, M. Pedrosa, C. Marcos, 2014, Annals of medicine.

SLIT: indications, follow-up, and management.

I. Dávila, M. Dieguez, E. González-Mancebo, 2014, Journal of investigational allergology & clinical immunology.

Development of a disease-specific quality of life questionnaire for adult patients with hereditary angioedema due to C1 inhibitor deficiency (HAE-QoL): Spanish multi-centre research project

E. Remor, V. Cardona, C. Marcos, 2012, Health and Quality of Life Outcomes.

Consensus document on dog and cat allergy

I. Dávila, M. Reche, E. González-Mancebo, 2018, Allergy.

Diagnosis of aspirin-induced asthma combining the bronchial and the oral challenge tests: a pilot study.

S. Quirce, P. Barranco, I. Bobolea, 2008, Journal of investigational allergology & clinical immunology.

Consensus statement on the diagnosis, management, and treatment of angioedema mediated by bradykinin. Part II. Treatment, follow-up, and special situations.

M. López-Trascasa, M. Pedrosa, C. Marcos, 2011, Journal of investigational allergology & clinical immunology.

Psychometric study of the SF-36v2 in hereditary angioedema due to C1 inhibitor deficiency (C1-INH-HAE)

W. Aberer, R. A. Campos, H. Farkas, 2021, Orphanet Journal of Rare Diseases.

Use of the lymphocyte transformation test in the diagnosis of DRESS syndrome induced by ceftriaxone and piperacillin-tazobactam: two case reports.

T. Bellón, S. Quirce, I. Bobolea, 2010, Journal of investigational allergology & clinical immunology.

Hereditary angioedema: health-related quality of life in Canadian patients as measured by the SF-36

Elaine Harniman, N. Prior, E. Pérez-Fernández, 2017, Allergy, Asthma & Clinical Immunology.

The international WAO/EAACI guideline for the management of hereditary angioedema – The 2021 revision and update

R. Lockey, R. Pawankar, W. Aberer, 2022, The World Allergy Organization journal.

Management of dental-oral procedures in patients with hereditary angioedema due to C1 inhibitor deficiency.

M. Pedrosa, R. Cabañas, M. C. Lopez-serrano, 2013, Journal of investigational allergology & clinical immunology.

Psychometric Field Study of Hereditary Angioedema Quality of Life Questionnaire for Adults: HAE-QoL.

W. Aberer, H. Farkas, E. Remor, 2016, The journal of allergy and clinical immunology. In practice.

HAE-AS, a specific disease activity scale for hereditary angioedema with C1-inhibitor deficiency.

N. Prior, A. Ayala, M. João Forjaz, 2020, Journal of investigational allergology & clinical immunology.

International consensus and practical guidelines on the gynecologic and obstetric management of female patients with hereditary angioedema caused by C1 inhibitor deficiency.

Tom Bowen, Erik Waage Nielsen, Hilary Longhurst, 2012, The Journal of allergy and clinical immunology.

International consensus on the diagnosis and management of pediatric patients with hereditary angioedema with C1 inhibitor deficiency

M. Triggiani, P. Schmid‐Grendelmeier, W. Aberer, 2016, Allergy.

Burden of Illness and Quality-of-Life Measures in Angioedema Conditions.

N. Prior, T. Caballero, 2017, Immunology and allergy clinics of North America.

Proton pump inhibitors are associated with hypersensitivity reactions to drugs in hospitalized patients: a nested case‐control in a retrospective cohort study

E. Ramírez, J. Frías, S. Quirce, 2013, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

Piperacillin-induced DRESS: distinguishing features observed in a clinical and allergy study of 8 patients.

E. Ramírez, T. Bellón, S. Quirce, 2014, Journal of investigational allergology & clinical immunology.

Abstracts from the 10th C1-inhibitor deficiency workshop

William H. Yang, A. Szilágyi, M. Margaglione, 2017, Allergy, Asthma & Clinical Immunology.

Consensus statement on the diagnosis, management, and treatment of angioedema mediated by bradykinin. Part I. Classification, epidemiology, pathophysiology, genetics, clinical symptoms, and diagnosis.

M. López-Trascasa, M. Pedrosa, C. Marcos, 2011, Journal of investigational allergology & clinical immunology.

Hereditary angioedema caused by the p.Thr309Lys mutation in the F12 gene: a multifactorial disease.

M. López-Trascasa, C. Drouet, N. Prior, 2013, The Journal of allergy and clinical immunology.

Definition, aims, and implementation of GA2LEN/HAEi Angioedema Centers of Reference and Excellence

Todor A Popov, T. Zuberbier, N. Papadopoulos, 2020, Allergy.

Evidence‐based recommendations for the therapeutic management of angioedema owing to hereditary C1 inhibitor deficiency: consensus report of an International Working Group

M. Triggiani, W. Aberer, R. Perricone, 2012, Allergy.

The international WAO/EAACI guideline for the management of hereditary angioedema—The 2017 revision and update

R. Lockey, R. Pawankar, W. Lumry, 2018, Allergy.